Dimitri Gridoriadis
Chief Research Officer
Neurocrine

Dr. Grigoriadis, is responsible for all research activities at Neurocrine. Dr. Grigoriadis is a recognized leader in CRF receptor antagonist development, has authored or co-authored over 200 publications in the neuroscience and neuropharmacology fields, and is a current Fellow of the American College of Neuropsychopharmacology (ACNP).

Dr. Grigoriadis joined Neurocrine in 1993 and was most recently Vice President of Discovery Biology. He was previously with the Neuroscience group at The Du Pont Pharmaceutical Company from 1990 to 1993. Dr. Grigoriadis received his B. Sc. from the University of Guelph in Ontario Canada, and his M.Sc. and Ph.D. in Pharmacology from the University of Toronto, Ontario, Canada. He conducted his postdoctoral research at the National Institute on Drug Abuse in Baltimore from 1987 to 1990.